Dr. Rachel Zabner Spielberger, MD

Dr. Zabner Spielberger practices at Cedars-Sinai Medical Center in Los Angeles, California, part of Cedars-Sinai Health System.

Dr. Zabner Spielberger's NPI, 1033149703, was assigned on July 5, 2006. Dr. Zabner Spielberger graduated from Central University of Venezuela in 1986. Dr. Zabner Spielberger's California license number on file is 53035.

Dr. Zabner Spielberger's primary practice is Cedars-Sinai Medical Center, at 8700 Beverly Blvd, Los Angeles, CA 90048 in Los Angeles County. The practice phone is (310) 423-5000.

Dr. Zabner Spielberger's primary practice is Cedars-Sinai Medical Center in Los Angeles, California, part of Cedars-Sinai Health System. The medical group on file is Cedars-Sinai Medical Group.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Zabner Spielberger practices. Vendor and product names are available with a free account.

Infectious disease is Dr. Zabner Spielberger's primary specialty in the NPI Registry, under taxonomy code 207RI0200X. Dr. Zabner Spielberger is board certified in infectious disease by the American Board of Internal Medicine. Dmand AI has Dr. Zabner Spielberger's licenses on file in 2 states: California and Illinois.

Dmand AI lists acute skin infection, hiv/aids, joint or bone infection, pneumonia, shingles and UTI among the conditions Dr. Zabner Spielberger treats.

CMS data shows 882 Medicare services from Dr. Zabner Spielberger across 9 procedure codes in 2024, for 317 Medicare patients. Medicare paid $90,295 for them.

CMS counts 317 Medicare patients who saw Dr. Zabner Spielberger in 2024. The largest group is 65 to 74, with 121 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 45% are also on Medicaid. Their average risk score is 3.51, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Zabner Spielberger's median patient age at 61, with 51% women.

In 2024, Dr. Zabner Spielberger wrote 481 Medicare Part D claims for 99 patients. 81% of them were for generic drugs. CMS names the drug for 355 of them, across 14 drugs with 11 or more claims each, at $252,084 in total drug cost. In 2023, CMS named 302 claims across 13 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 89 out of 100 for Dr. Zabner Spielberger for performance year 2024, reported as part of a group. Dr. Zabner Spielberger accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Zabner Spielberger as offering telehealth.

CMS Open Payments shows 8 general payments to Dr. Zabner Spielberger from 6 drug and device companies from 2016 to 2025. Education make up the largest share, 61% of the total. Astellas Pharma US Inc paid the most, $198.

Dmand AI lists 1 award for Dr. Zabner Spielberger, most recently CMS Stage 1 EHR in 2013.

Dr. Zabner Spielberger graduated from Central University of Venezuela in 1986.

Dr. Zabner Spielberger is in network with 8 carriers, including Aetna, Blue Cross Blue Shield of Michigan and United Healthcare. Medicare plans come from the most carriers, 7. Check the plan with the practice before a visit.